Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc
Bullboard Posts
User Avatar Image
(3)
•••
Comment by WileyCyteon Nov 06, 2017 11:37am
76 Views
Post# 26911865

RE:RE:Not impressed!

RE:RE:Not impressed!This company's track has been disappointing to say the least. I have followed their progress for some time and own shares long. In good faith I have taken at face value their investor presentation that outlines how the company would like to develop and perform. But my goodness, they just don't seem to move their business model forward in any appreciable way. What a masive disappointment the past two years have been. The only positive I can take away from these private placements is that it means several deep-pocketed insider investors continue to see value somwhere. Unfortunately the company dilutes us with each PP. If they were announcing any positive news at all regarding sales and contracts, I'd be OK with it, but they just don't seem to generate any revenue at all. I'll be looking to unload this dud as soon as I break even. What a shame. Beware penny stocks I guess. They are worth pennies for a reason. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities